Will you join the mission to help stop myeloma before it starts?
You may be uniquely suited to help find the cure if you're either African American or a first-degree family member of someone with signs of blood-related pre-cancer. We invite you to join!
OUR STUDY
THE PROMISE study is the first study to test healthy people who may be at risk for early warning signs of a blood cancer called multiple myeloma.
We will further study people who test positive for these early warning signs of multiple myeloma so that we can learn how to prevent them from developing into cancer.
OUR GOALS
This study aims to make multiple myeloma a cancer that is preventable.
PROMISE Study Videos
Our Promise To Share Hope
Promise Study Introduction
Who can join and get screened at no cost?
2 groups of U.S. adults, age 45-75, qualify for a free screening:
1. African Americans
AND / OR
2. People of Any Race Who Have a Parent, Sibling, or Child with:
Multiple myeloma OR one these related conditions:
Please sign up for the study if you qualify and invite other family members to join too.
Note: This study is for people who may have higher risks, but have not been diagnosed. If you have been diagnosed with one of the above conditions, please visit our PCROWD study, a sister study designed for you.
?
Thank you for your interest in this mission. We encourage anyone to invite people who may qualify for a screening.
How do I join and get screened for free?
2. Accept Terms
Take a short survey and decide whether to go to the next step. We are fully committed to protecting your privacy. Study data is used only for research.
3. Receive Kit
Once you have completed the enrollment and are qualified for a free screening, we will send a collection kit to you at no cost.
4. Schedule
Screening
When the kit arrives, it will contain instructions for how to schedule your free screening at a Quest Diagnostics lab near you, where they will collect a small amount of blood to be tested.
5. Get Results
We will check your blood sample for certain proteins that we call "precursor conditions" for multiple myeloma - a type of blood cancer.
We will notify all participants of their results. Everyone who participates is helping researchers find new ways to prevent and treat blood cancer.